CoChat

Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV- GAA ) Gene Vector in Patients with Pompe Disease

Byrne, Barry J., Smith, Barbara, Mah, Cathryn, Lawson, Lee Ann, Islam, Saleem, Corti, Manuela, Martin, Daniel, Dobija, Nicole, Irwin, Maria V., Conlon, Thomas, Cleaver, Brian, Clement, Nathalie, Collins, Shelley W. · 2014 · Human Gene Therapy Clinical Development
Cited by 46

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

A recombinant virus vector constructed from adeno-asso-ciated virus (AAV) has been engineered to carry the humanacid alpha-glucosidase (hGAA) gene expressed from thecytomegalovirus (CMV) enhancer/promoter. The constructhas been shown to produce hGAA in animal models ofPompe disease, which directly matches the proposed humanstudies. The proposed clinical trial is an open label, phase I/II study administering rAAV1-CMV-GAAgene vector in-tramuscularly into the diaphragms of human subjects withPompe disease. Safety parameters will be measurement ofchange in: serum chemistries and hematology, urinalysis,muscle function testing, whole blood assay for vector ge-nomes, immunologic response to GAA and AAV, as well asreported subject symptom history.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/humc.2014.2514

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 46

Metadata

Authors
Byrne, B. J., Smith, B., Mah, C., Lawson, L. A., Islam, S., Corti, M., Martin, D., Dobija, N., Irwin, M. V., Conlon, T., Cleaver, B., Clement, N., & Collins, S. W.
Venue
Human Gene Therapy Clinical Development
Published
2014-09
Volume
25
Issue
3
Pages
134-163
ISSN
  • 2324-8637 (ISSN-L)
  • 2324-8645
OpenAlex
W1573022004
Cited by
46
References
18
FWCI
1.94
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV- GAA ) Gene Vector in Patients with Pompe Disease. https://app.cochat.ai/papers/10.1089/humc.2014.2514
The paper
Byrne, B. J., Smith, B., Mah, C., Lawson, L. A., Islam, S., Corti, M., Martin, D., Dobija, N., Irwin, M. V., Conlon, T., Cleaver, B., Clement, N., & Collins, S. W. (2014). Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV- GAA ) Gene Vector in Patients with Pompe Disease. Human Gene Therapy Clinical Development. https://doi.org/10.1089/humc.2014.2514

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.